These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4037902)

  • 1. Implantable infusion pump management of insulin resistant diabetes mellitus.
    Buchwald H; Chute EP; Goldenberg FJ; Hitchcock CR; Hoogwerf BJ; Barbosa JJ; Rupp WM; Rohde TD
    Ann Surg; 1985 Sep; 202(3):278-82. PubMed ID: 4037902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An implantable insulin infusion pump for the patient with diabetes mellitus resistant to subcutaneously administered insulin].
    van Ballegooie E; Oosten HR
    Ned Tijdschr Geneeskd; 1984 Mar; 128(11):502-4. PubMed ID: 6709089
    [No Abstract]   [Full Text] [Related]  

  • 3. Extreme subcutaneous, intramuscular and inhaled insulin resistance treated by pancreas transplantation alone.
    Sa JR; Alvarenga MA; Rangel EB; Melaragno CS; Gonzalez AM; Linhares MM; Salzedas A; Carmona AK; Tonetto-Fernandes V; Gabbay MA; Medina Pestana JO; Dib SA
    Am J Transplant; 2010 Jan; 10(1):184-8. PubMed ID: 19958338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
    Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
    Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brittle diabetes revisited: a description of erratic and difficult-to-control diabetes in an elderly woman with Type 1 diabetes.
    Newman C; Dinneen SF
    Diabet Med; 2020 Oct; 37(10):1777-1780. PubMed ID: 31004371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extreme subcutaneous and intramuscular insulin resistance at type 1 diabetes mellitus].
    Pinheiro A; Tácito LH; Pires AC
    Arq Bras Endocrinol Metabol; 2011 Apr; 55(3):233-7. PubMed ID: 21655874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of extremely brittle, insulin-dependent diabetes with a novel subcutaneous insulin pump regimen.
    Nathan DM
    Diabetes Care; 1982; 5(2):105-10. PubMed ID: 6821487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
    Riddle MC; Nahra R; Han J; Castle J; Hanavan K; Hompesch M; Huffman D; Strange P; Öhman P
    Diabetes Care; 2018 Nov; 41(11):2346-2352. PubMed ID: 30213882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
    Talaulicar M; Willms B
    Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences with diabetes mellitus and implantable insulin pump therapy: a summary of interview data.
    Meize-Grochowski AR
    Diabetes Educ; 1989; 15(1):50-5. PubMed ID: 2910689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.